CliniGA CRO

CliniGA CRO Blog

Handing over open matters in country regulatory communications

Changing a country regulatory contact may require more than updating an address list.

Representative research photograph: Handing over open matters in country regulatory communications
Photo: NIDA(NIH) · License: Public domain · Cropped and resized.
Published
Updated

Changing a country regulatory contact may require more than updating an address list. Outstanding questions, earlier advice and knowledge of local processes need transfer. Sponsors should distinguish an internal role change from a formal change of representation or authorisation rather than treating them as one automatic administrative event.

Decision framework

Verify the role's scope and supporting authority with appropriate legal and regulatory owners. Establish what information the successor receives, which external communications they may make and which matters require referral. Creating a platform account does not automatically demonstrate completion of necessary formal authorisation. Country-specific steps require their own appropriate verification.

Worked example

For example, a new consultant inherits a dossier without knowing why an earlier response took a particular position. A similar question could receive contradictory information. The handover brings open issues, source documents and previous decisions together. The successor can understand the current approach and request reassessment through an appropriate decision route if necessary.

Implementation checks

  • Show open external communications, expected responses and supporting source documents together in one clear handover list.
  • Verify that the new person's internal remit is consistent with their external authority through the appropriate authorised owners.
  • After transition, check that incoming messages reach the correct person and that the former communication channel is managed appropriately.

Acceptance and boundaries

Accept handover when the successor can explain country status with evidence and understands authority limits. This example prescribes no particular country's representative-appointment rules. Specialists should assess formal notification, authorisation or agreement changes separately; an internal organisation chart is not sufficient proof that those steps have occurred.

Frequently asked questions

Is a new contact automatically the formal representative?
No. Assess the role and any necessary authorisation separately.
Should every historical email be forwarded?
Transfer necessary context while respecting confidentiality and the relevant information scope.

Sources

  1. EMA — CTIS sponsor handbook and support
  2. European Commission — Clinical trials framework